Dr. Reddy’s Q4 & FY15 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/29/2026
- Wall Street ends higher as US, Iran attacks ease; major tech-related shares jump
- Tech funds suffer record outflows as investors trim equity positions
- Comcast shares surge 23% on blockbuster plan to spin off NBCUniversal and Sky
- New leader board: Citi refreshes AI compute semiconductor picks
- Martin Marietta confirms $13.5B deal for Lhoist North America
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- Needham Starts NeoVolta (NEOV) at Buy
- Personalis, Inc. (PSNL) and Tempus (TEM) Expand Collaboration
- EchoStar Prepares Dish DBS Bankruptcy Filing as Soon as Tuesday - WSJ
- Strategy stock jumps 7% as firm shifts to active capital management
Dr. Reddys Labs (RDY) Reports Q4 EPS of $0.49
May 12, 2015 7:23 AM EDTDr. Reddys Labs (NYSE: RDY) reported Q4 EPS of $0.49, versus $0.45 reported last year. Revenue for the quarter came in at $621 million, versus $559 million reported last year.
For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.
... More